Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba extract EGb 761®

Planta Medica

Volumn 76, Issue 15, 2010, Pages 1683-1690

  Rangel Ordóñez, Laura ^a   Nöldner, Michael ^b   Schubert Zsilavecz, Manfred ^a   Wurglics, Mario ^a  

^a GOETHE UNIVERSITY   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

brain bioavailability; EGb 761; flavonoid glycosides; Ginkgo biloba; Ginkgoaceae; HPLCfluorescence; pharmacokinetic; plasma

Indexed keywords

FLAVONOID; GINKGO BILOBA EXTRACT; ISORHAMNETIN; KAEMPFEROL; QUERCETIN; TAMARIXETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; FLAVONOIDS; FLAVONOLS; KAEMPFEROLS; MALE; PLANT EXTRACTS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY;

GINKGO BILOBA; GINKGOACEAE; RATTUS;

EID: 77958534784     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1249962     Document Type: Article

References (42)

1. van Beek T A. Chemical analysis of Ginkgo biloba leaves and extracts. Free Radic Biol Med 2002 967 21-55
2. Sticher O. Quality of Ginkgo preparations. Free Radic Biol Med 1993 59 2-11
3. Christen Y. Oxidative stress and Alzheimer disease. Free Radic Biol Med 2000 71 621S-629S
4. Markesbery W R., Lovell M A. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Free Radic Biol Med 2007 64 954-956
5. Ramassamy C. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype cholesterol transport protein with expanding role in cell biology. Free Radic Biol Med 1999 27 544-553
6. Wei T, Ni Y, Hou J, Chen C, Zhao B, Xin W. Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: protection by Ginkgo biloba extract. Pharmacol Res 2000 41 427-433
7. Xin W, Wei T, Chen C, Ni Y, Zhao B, Hou J. Mechanisms of apoptosis in rat cerebellar granule cells induced by hydroxyl radicals and the effects of EGb761 and its constituents. Toxicology 2000 148 103-110
8. Smith J V., Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Free Radic Biol Med 2004 64 465-472
9. Ramassamy C, Longpré F, Christen Y. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence? Curr Alzheimer Res 2007 4 253-262
10. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder J B., Eckert A, Müller W E. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Free Radic Biol Med 2007 9 1659-1675
11. Vafeiadou K, Vauzour D, Spencer J P. E. Neuroinflammation and its modulation by flavonoids. Free Radic Biol Med 2007 7 211-224
12. Hollman P C., vd Gaag M, Mengelers M J., van Trijp J M., de Vries J H., Katan M B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996 21 703-707
13. Manach C, Morand C, Crespy V, Demigné C, Texier O, Régérat F, Rémésy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 1998 426 331-336
14. Graefe E U., Wittig J, Mueller S, Riethling A K., Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 2001 41 492-499
15. Boyle S P., Dobson V L., Duthie S J., Hinselwood D C., Kyle J A., Collins A R. Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. Eur J Clin Nutr 2000 54 774-782
16. Erlund I, Kosonen T, Alfthan G, Mäenpää J, Perttunen K, Kenraali J, Parantainen J, Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000 56 545-553
17. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005 81 243S-255S
18. Nieder M. Pharmakokinetik der Ginkgo-Flavonole im Plasma. Munch Med Wochenschr 1991 133 61-62
19. Wójcicki J, Gawroska-Szklarz B, Bieganowski W, Patalan M, Smulski H K., Samochowiec L, Zakrzewski J. Comparative pharmacokinetics and bioavailability of flavonoid glycosides of Ginkgo biloba after a single oral administration of three formulations to healthy volunteers. Mater Med Pol 1995 27 141-146
20. Zhao Y, Sun Y, Li C. Simultaneous determination of ginkgo flavonoids and terpenoids in plasma: ammonium formate in LC mobile phase enhancing electrospray ionization efficiency and capacity. J Am Soc Mass Spectrom 2008 19 445-449
21. Juergenliemk G, Boje K, Huewel S, Lohmann C, Galla H, Nahrstedt A. In vitro studies indicate that miquelianin (quercetin 3-O-beta-D- glucuronopyranoside) is able to reach the CNS from the small intestine. Planta Med 2003 69 1013-1017
22. Paulke A, Schubert-Zsilavecz M, Wurglics M. Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2006 832 109-113
23. Moreau J P., Eck C R., McCabe J, Skinner S. [Absorption, distribution and elimination of a labelled extract of Ginkgo biloba leaves in the rat]. Presse Med 1986 15 1458-1461
24. Abrahamse S L. Absorption, distribution, and secretion of epicatechin and quercetin in the rat. Nutr Res 2005 25 305-317
25. Cermak R. The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J Nutr 2003 133 2802-2807
26. Wolffram S, Blöck M, Ader P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr 2002 132 630-635
27. Morand C, Crespy V, Manach C, Besson C, Demigné C, Rémésy C. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 1998 275 R212-R219
28. Day A J., Mellon F, Barron D, Sarrazin G, Morgan M R., Williamson G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 2001 35 941-952
29. Oliveira E J., Watson D G., Grant M H. Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma. Xenobiotica 2002 32 279-287
30. O'Leary K A., Day A J., Needs P W., Mellon F A., O'Brien N M., Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003 65 479-491
31. Watson D G., Oliveira E J. Solid-phase extraction and gas chromatography-mass spectrometry determination of kaempferol and quercetin in human urine after consumption of Ginkgo biloba tablets. J Chromatogr B Biomed Sci Appl 1999 723 203-210
32. Ader P, Wessmann A, Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000 28 1056-1067
33. Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J, Popadaj B, Ernsberger P, Roth B L. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs. Psychopharmacology (Berl) 2002 162 193-202
34. Kommission E. Ginkgo biloba leaf extract Ginkgo folium. Köln Bundesanzeiger Verlagsgesellschaft 1994
35. Watson D G., Pitt A R. Analysis of flavonoids in tablets and urine by gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 1998 12 153-156
36. Bolarinwa A, Linseisen J. Validated application of a new high-performance liquid chromatographic method for the determination of selected flavonoids and phenolic acids in human plasma using electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005 823 143-151
37. Hollman P C. H. Fluorescence detection of flavonols in HPLC by postcolumn chelation with aluminum. Anal Chem 1996 68 3511-3515
38. Watanabe C M., Wolffram S, Ader P, Rimbach G, Packer L, Maguire J J., Schultz P G., Gohil K. The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 2001 98 6577-6580
39. Lowry O H., Rosebrough N J., Farr A L., Randall R J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 193 265-275
40. Paulke A, Nöldner M, Schubert-Zsilavecz M, Wurglics M. St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie 2008 63 296-302
41. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991 82 239-259
42. Upton R N. Cerebral uptake of drugs in humans. Clin Exp Pharmacol Physiol 2007 34 695-701